financetom
Business
financetom
/
Business
/
Capital Southwest Reports Preliminary Q1 Net Investment Income
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Capital Southwest Reports Preliminary Q1 Net Investment Income
Jul 15, 2025 2:34 PM

05:02 PM EDT, 07/15/2025 (MT Newswires) -- Capital Southwest ( CSWC ) said late Tuesday that its preliminary estimate of Q1 2026 pre-tax net investment income is in the range of $0.60 to $0.61 per share.

The company also said that its preliminary estimate of net investment income for the same period is in the range of $0.58 to $0.59 per share.

Analysts polled by FactSet expect $0.60.

Additionally, the preliminary estimate of its net asset value per share, as of June 30, is in the range of $16.55 to $16.65, said the company.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Up to 10 companies bid for Deutsche Bahn's Schenker, Handelsblatt reports
Up to 10 companies bid for Deutsche Bahn's Schenker, Handelsblatt reports
Mar 26, 2024
BERLIN (Reuters) - Between seven and 10 companies have made non-binding offers for Schenker, the logistics subsidiary of German national rail company Deutsche Bahn, the Handelsblatt business daily reported on Wednesday, citing sources familiar with the matter. Among those companies are Danish group DSV and shipping company Maersk, as well as financial investors, according to the report. The group of...
US FDA approves Merck's therapy for rare lung condition
US FDA approves Merck's therapy for rare lung condition
Mar 26, 2024
(Reuters) -The U.S. Food and Drug Administration on Tuesday approved Merck's treatment for adults with high blood pressure due to constriction of lung arteries, adding another potential blockbuster drug to the pharmaceutical giant's portfolio. Shares of Merck were up more than 4% in extended trading. The therapy, branded Winrevair, is approved for treating pulmonary arterial hypertension (PAH), which affects about...
Viking Therapeutics' weight-loss tablet shows promise in small study
Viking Therapeutics' weight-loss tablet shows promise in small study
Mar 26, 2024
(Reuters) -Viking Therapeutics' experimental tablet reduced weight by as much as 3.3% when tested in volunteers enrolled in a small early-stage trial, meeting Wall Street expectations and sending the company's shares up 15% in premarket trading on Tuesday. Popular market leaders from Eli Lilly and Novo Nordisk are administered under-the-skin, with companies also testing oral versions that they hope will...
PRESS DIGEST- Wall Street Journal - March 27
PRESS DIGEST- Wall Street Journal - March 27
Mar 26, 2024
March 27 (Reuters) - Following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - Johnson & Johnson ( JNJ ) is in talks to acquire the medical-device maker Shockwave Medical ( SWAV ) and a deal could be completed in the coming weeks. - Wearable-camera maker...
Copyright 2023-2026 - www.financetom.com All Rights Reserved